Emcure Pharmaceuticals confirms compliance with SEBI regulations for the quarter ended December 31, 2025, based on a certificate received from MUFG Intime India Private Limited, the Registrar and Share Transfer Agent (RTA). The confirmation pertains to the dematerialization of securities and ensures that all related certificates have been duly processed and listed on the stock exchanges.
Confirmation of Dematerialization
Emcure Pharmaceuticals has received a certificate from its Registrar and Share Transfer Agent (RTA), MUFG Intime India Private Limited, confirming the processing of security certificates for dematerialization. This confirmation is for the quarter ended December 31, 2025.
Details of Compliance
The certificate confirms that securities received for dematerialization have been duly processed, and the corresponding certificates have been listed on the stock exchanges. MUFG Intime India Private Limited verified that the security certificates received for dematerialization were processed and cancelled after verification. The register of members has been updated to reflect the changes in ownership.
Source: BSE
